Vitamin B12 500 mcg
Natural health product licensed in Canada
- Licence holder
- Vitazan Herbs and Vitamins Inc
- NPN or DIN-HM
- 80097698
- Status
- Active licence
- Licence date
- 19 March 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Beta vulgaris Source : Racine | 300 mg | Not calculated |
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 mg | 40 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 0.0333 FCC FTU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 40 FCC LU | Not calculated |
| Diastase du malt Source : Hordeum vulgare - graine | 1.733 FCC DU | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 552.5 FCC HUT | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 0.6666 FCC HUT | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : En entier | 1.05 FCC INVU | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces spp. | 1.05 FCC INVU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 157.5 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Handroanthus heptaphyllus Source : Écorce interne | 50 mg | Not calculated |
| Papaïne Source : Carica papaya - fruit | 4,000 FCC PU | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 500 mcg | 500 µg |
Non-medicinal ingredients
Eau purifiée, Dioxyde de silicium, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes or galactosemia. Discontinue use and consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking anti-inflammatory or other enzyme products. Consult a health care practitioner prior to use if you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato). Consult a health care practitioner prior to use if you are have gastrointestinal lesions/ulcers or are having surgery. Do not use if you have liver or gall bladder disorders, and/or bowel obstruction. Discontinue use if you develop symptoms of liver trouble such as abdominal pain, dark urine or jaundice. Do not take if you have a heart condition or are on anticoagulants. Consult a health care practitioner prior to use if you are taking antibiotics.
- Effets indésirables connus
Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use. May cause bloating, cramping, and constipation.
Source
Official Health Canada record, licence 80097698
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.